2 completed, 1 recruiting, 1 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Recruiting 1, Unknown 1 |
Follow Uludag University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome Poractant alfa, Calfactant - Respiratory Distress Syndrome in Premature Infants, Respiratory Distress Syndrome (RDS) | Phase 4 | Recruiting | Uludag University | 234 | 2026-01-20 | 2026-04-28 |
| OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP Minimally invasive surfactant therapy, Continuation on CPAP - Bronchopulmonary Dysplasia | Phase 4 | Unknown | Menzies Institute for Medical Research | 486 | 2011-12-01 | 2020-05-01 |
| The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine Levobupivacaine, Bupivacaine, placebo - Hypertension | Phase 4 | Completed | Uludag University | 90 | 2008-03-01 | 2018-01-05 |
| Cognitive Functions After TIVA With Dexmedetomidine Remifentanil, Propofol, Dexmedetomidine - Postoperative Confusion | Phase 4 | Completed | Uludag University | 40 | 2008-01-01 | 2024-05-17 |
Bronchopulmonary Dysplasia (1) · Hypertension (1) · Premature Birth (1) · Respiratory Distress Syndrome (1) · Respiratory Distress Syndrome In Premature Infants (1)
Bupivacaine (1) · Dexmedetomidine (1) · Levobupivacaine (1) · Propofol (1) · Remifentanil (1) · Rocuronium (1) · Sodium Chloride (1) · calfactant (1) · poractant alfa (1)
Turkey (Türkiye) (3) · Australia (1) · Israel (1) · New Zealand (1) · Slovenia (1) · United States (1)
Hulya Bilgin, professor (1) · Peter A Dargaville, MD (1)